Press Releases on May 4, 2017 - EIN Presswire - Press Release Distribution Service

Published on May 4, 2017 - 11:05 GMT

Savory Yogurt Foods 2017 Global Market Size,Status and Forecast to 2022

WiseGuyReports.Com Adds “Savory Yogurt Foods Market 2017 Growth,Share,Trends,Demand & Analysis of Top Key Players to 2021” Research to its database. PUNE, INDIA, May 4, 2017 /EINPresswire.com/ -- In this report, the global Savory Yogurt Foods …

Distribution channels: Agriculture, Farming & Forestry Industry, Business & Economy ...

Published on May 4, 2017 - 11:05 GMT

Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update

Worldwide net Ocaliva® (obeticholic acid or OCA) 1Q 2017 sales of $20.6 million Completed enrollment of Phase 3 REGENERATE trial interim analysis cohort: data expected in 1H 2019 Conference call scheduled for 8:30 a.m. ET today NEW YORK, May 04, 2017 ( …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on May 4, 2017 - 11:04 GMT

Smart Cities in Latin America Market Analysis 2017 (By Segment, Key Players and Opportunity) and Forecasts To 2022

Smart Cities in Latin America Market Share, Opportunities, Segmentation and Forecast to 2022 PUNE, INDIA, May 4, 2017 /EINPresswire.com/ -- Summary "Smart Cities in Latin America: Smart Grids and Big Data Create Opportunities for Telcos to …

Distribution channels: Building & Construction Industry, Business & Economy ...

Published on May 4, 2017 - 11:03 GMT

Life Sciences BPO Global Market Segmentation, Growth Drivers, Challenges, Key Players, Scope, Context and FOrecast 2022

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies PUNE, INDIA, May 4, 2017 /EINPresswire.com/ -- The Global Life Sciences BPO Market Research Report …

Distribution channels: Business & Economy, Media, Advertising & PR ...

Published on May 4, 2017 - 11:02 GMT

Keryx Biopharmaceuticals Announces First Quarter 2017 Financial Results

Company reported $11.8 million in first quarter 2017 total revenue, including net U.S. Auryxia® (ferric citrate) product sales of $10.5 million Provides 2017 net U.S. Auryxia product sales guidance of $56 to $60 million Target action date of November 6, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on May 4, 2017 - 11:01 GMT

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

DANVERS, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced today the enrollment of the first patient in the Food and Drug Administration (FDA) approved prospective …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 4, 2017 - 11:01 GMT

Agios Reports First Quarter 2017 Financial Results

– IDHIFA® (enasidenib) Granted Priority Review by FDA with August 30, 2017 PDUFA Date; Updated Data from Phase 1/2 Trial in IDH2m R/R AML to be Presented at ASCO – – Ivosidenib Phase 1 125-Patient Expansion Cohort in IDH1m R/R AML Fully Enrolled; NDA …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry